276 related articles for article (PubMed ID: 17907058)
1. Selective androgen receptor modulators for frailty and osteoporosis.
Kilbourne EJ; Moore WJ; Freedman LP; Nagpal S
Curr Opin Investig Drugs; 2007 Oct; 8(10):821-9. PubMed ID: 17907058
[TBL] [Abstract][Full Text] [Related]
2. Novel, non-steroidal, selective androgen receptor modulators (SARMs) with anabolic activity in bone and muscle and improved safety profile.
Rosen J; Negro-Vilar A
J Musculoskelet Neuronal Interact; 2002 Mar; 2(3):222-4. PubMed ID: 15758439
[TBL] [Abstract][Full Text] [Related]
3. Selective androgen receptor modulators: in pursuit of tissue-selective androgens.
Omwancha J; Brown TR
Curr Opin Investig Drugs; 2006 Oct; 7(10):873-81. PubMed ID: 17086931
[TBL] [Abstract][Full Text] [Related]
4. Development of selective androgen receptor modulators and their therapeutic applications.
Chen F; Rodan GA; Schmidt A
Zhonghua Nan Ke Xue; 2002; 8(3):162-8. PubMed ID: 12478835
[TBL] [Abstract][Full Text] [Related]
5. Substituted 6-(1-pyrrolidine)quinolin-2(1H)-ones as novel selective androgen receptor modulators.
Martinborough E; Shen Y; Oeveren Av; Long YO; Lau TL; Marschke KB; Chang WY; López FJ; Vajda EG; Rix PJ; Viveros OH; Negro-Vilar A; Zhi L
J Med Chem; 2007 Oct; 50(21):5049-52. PubMed ID: 17887661
[TBL] [Abstract][Full Text] [Related]
6. Synthetic anabolic agents: steroids and nonsteroidal selective androgen receptor modulators.
Thevis M; Schänzer W
Handb Exp Pharmacol; 2010; (195):99-126. PubMed ID: 20020362
[TBL] [Abstract][Full Text] [Related]
7. [Hormone replacement Up-to-date. Selective androgen receptor modulators (SARMs). Current status and their future].
Tsukamoto T; Kato R; Kobayashi K
Clin Calcium; 2007 Sep; 17(9):1424-8. PubMed ID: 17767034
[TBL] [Abstract][Full Text] [Related]
8. [Diagnosis and treatment of osteoporosis in male hypogonadism].
Tsukamoto T; Itoh N
Clin Calcium; 2006 Mar; 16(3):481-5. PubMed ID: 16508132
[TBL] [Abstract][Full Text] [Related]
9. Do androgens play any role in the physical frailty of ageing men?
O'Connell MD; Tajar A; Roberts SA; Wu FC
Int J Androl; 2011 Jun; 34(3):195-211. PubMed ID: 20722765
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in the development of selective androgen receptor modulators.
Zhang X; Lanter JC; Sui Z
Expert Opin Ther Pat; 2009 Sep; 19(9):1239-58. PubMed ID: 19505196
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and SAR of tetrahydropyrrolo[1,2-b][1,2,5]thiadiazol-2(3H)-one 1,1-dioxide analogues as highly potent selective androgen receptor modulators.
Manfredi MC; Bi Y; Nirschl AA; Sutton JC; Seethala R; Golla R; Beehler BC; Sleph PG; Grover GJ; Ostrowski J; Hamann LG
Bioorg Med Chem Lett; 2007 Aug; 17(16):4487-90. PubMed ID: 17574413
[TBL] [Abstract][Full Text] [Related]
12. Androgens and bone health.
Hansen KA; Tho SP
Semin Reprod Endocrinol; 1998; 16(2):129-34. PubMed ID: 9711678
[TBL] [Abstract][Full Text] [Related]
13. [Effects of androgen on the bone].
Zhou T; Zhou ZL
Zhonghua Nan Ke Xue; 2005 May; 11(5):371-4. PubMed ID: 15934464
[TBL] [Abstract][Full Text] [Related]
14. [A potential of selective androgen receptor modulator(SARM)for the therapy of osteoporosis].
Yanase T
Clin Calcium; 2016 Jul; 26(7):1023-30. PubMed ID: 27346314
[TBL] [Abstract][Full Text] [Related]
15. A novel selective androgen receptor modulator, NEP28, is efficacious in muscle and brain without serious side effects on prostate.
Akita K; Harada K; Ichihara J; Takata N; Takahashi Y; Saito K
Eur J Pharmacol; 2013 Nov; 720(1-3):107-14. PubMed ID: 24177288
[TBL] [Abstract][Full Text] [Related]
16. Novel series of potent, nonsteroidal, selective androgen receptor modulators based on 7H-[1,4]oxazino[3,2-g]quinolin-7-ones.
Higuchi RI; Arienti KL; López FJ; Mani NS; Mais DE; Caferro TR; Long YO; Jones TK; Edwards JP; Zhi L; Schrader WT; Negro-Vilar A; Marschke KB
J Med Chem; 2007 May; 50(10):2486-96. PubMed ID: 17439112
[TBL] [Abstract][Full Text] [Related]
17. Development of selective androgen receptor modulators (SARMs).
Narayanan R; Coss CC; Dalton JT
Mol Cell Endocrinol; 2018 Apr; 465():134-142. PubMed ID: 28624515
[TBL] [Abstract][Full Text] [Related]
18. Identification of anabolic selective androgen receptor modulators with reduced activities in reproductive tissues and sebaceous glands.
Schmidt A; Harada SI; Kimmel DB; Bai C; Chen F; Rutledge SJ; Vogel RL; Scafonas A; Gentile MA; Nantermet PV; McElwee-Witmer S; Pennypacker B; Masarachia P; Sahoo SP; Kim Y; Meissner RS; Hartman GD; Duggan ME; Rodan GA; Towler DA; Ray WJ
J Biol Chem; 2009 Dec; 284(52):36367-36376. PubMed ID: 19846549
[TBL] [Abstract][Full Text] [Related]
19. Androgens and Selective Androgen Receptor Modulators to Treat Functional Limitations Associated With Aging and Chronic Disease.
Bhasin S; Krishnan V; Storer TW; Steiner M; Dobs AS
J Gerontol A Biol Sci Med Sci; 2023 Jun; 78(Suppl 1):25-31. PubMed ID: 37325955
[TBL] [Abstract][Full Text] [Related]
20. An orally active selective androgen receptor modulator is efficacious on bone, muscle, and sex function with reduced impact on prostate.
Miner JN; Chang W; Chapman MS; Finn PD; Hong MH; López FJ; Marschke KB; Rosen J; Schrader W; Turner R; van Oeveren A; Viveros H; Zhi L; Negro-Vilar A
Endocrinology; 2007 Jan; 148(1):363-73. PubMed ID: 17023534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
